-
Despite FDA approval of the brand name Aduhelm and its generic aducanumab and criticism from the Alzheimer’s Association, the Clinic says its doctors can prescribe the medications, but patients will need to get the treatments elsewhere.
-
State health officials say the delta variant of the coronavirus is rapidly increasing and is on track to become the dominant strain in Ohio; Gov. Mike DeWine has signed a bill into law that forbids public schools and colleges from requiring individuals to receive vaccines not granted full approval by the U.S. FDA; the Cleveland Clinic will not be administering a new Alzheimer’s drug for now; and more stories.